trending Market Intelligence /marketintelligence/en/news-insights/trending/yauruo9fz0owjhmpsym-3a2 content esgSubNav
In This List

Biocure Technology director resigns; replacement named

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Biocure Technology director resigns; replacement named

Canada's Biocure Technology Inc. said Marco Nonni resigned as a director.

Nonni joined the company's board in April, and will continue working with Biocure Technology on a consulting basis.

The company appointed Hans Frykman to replace Nonni, effective Sept. 4.

Frykman is medical director at Neurocode Labs and UBC Diagnostic Services Lab.

Biocure Technology develops and commercializes biosimilar pharmaceutical products in South Korea.